1. Home
  2. ASC vs ESPR Comparison

ASC vs ESPR Comparison

Compare ASC & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardmore Shipping Corporation

ASC

Ardmore Shipping Corporation

HOLD

Current Price

$15.98

Market Cap

683.9M

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.14

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASC
ESPR
Founded
2010
2008
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
683.9M
731.9M
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
ASC
ESPR
Price
$15.98
$3.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$17.00
$8.75
AVG Volume (30 Days)
713.6K
17.5M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
1.74%
N/A
EPS Growth
N/A
60.71
EPS
N/A
N/A
Revenue
N/A
$403,135,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.81
P/E Ratio
$16.60
N/A
Revenue Growth
N/A
21.31
52 Week Low
$9.18
$0.85
52 Week High
$20.03
$4.18

Technical Indicators

Market Signals
Indicator
ASC
ESPR
Relative Strength Index (RSI) 34.08 70.44
Support Level $14.91 $3.11
Resistance Level $16.91 $3.18
Average True Range (ATR) 0.73 0.01
MACD -0.44 -0.02
Stochastic Oscillator 4.98 62.50

Price Performance

Historical Comparison
ASC
ESPR

About ASC Ardmore Shipping Corporation

Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The company markets its services directly to its customers and commercial pool operators and charters its vessels to them through a combination of spot, commercial pooling, and time-charter arrangements. The majority of its revenue is generated from spot voyages, which typically last less than three months.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: